208 related articles for article (PubMed ID: 32319674)
21. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
[TBL] [Abstract][Full Text] [Related]
22. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis.
Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.
Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
Medicine (Baltimore); 2016 May; 95(19):e3641. PubMed ID: 27175682
[TBL] [Abstract][Full Text] [Related]
24. An Oxidative Stress Index-Based Score for Prognostic Prediction in Colorectal Cancer Patients Undergoing Surgery.
Cao Y; Deng S; Yan L; Gu J; Mao F; Xue Y; Zheng C; Yang M; Liu H; Liu L; Liu Q; Cai K
Oxid Med Cell Longev; 2021; 2021():6693707. PubMed ID: 33505587
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of elevated preoperative neutrophil-to-lymphocyte ratio for patients with colorectal cancer undergoing curative surgery: A meta-analysis.
Li H; Zhao Y; Zheng F
Medicine (Baltimore); 2019 Jan; 98(3):e14126. PubMed ID: 30653142
[TBL] [Abstract][Full Text] [Related]
26. Whole blood DNA methylation aging markers predict colorectal cancer survival: a prospective cohort study.
Gào X; Zhang Y; Boakye D; Li X; Chang-Claude J; Hoffmeister M; Brenner H
Clin Epigenetics; 2020 Nov; 12(1):184. PubMed ID: 33256852
[TBL] [Abstract][Full Text] [Related]
27. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
28. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
[TBL] [Abstract][Full Text] [Related]
29. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
30. Low radiographic muscle density is associated with lower overall and disease-free survival in early-stage colorectal cancer patients.
van Baar H; Beijer S; Bours MJL; Weijenberg MP; van Zutphen M; van Duijnhoven FJB; Slooter GD; Pruijt JFM; Dronkers JJ; Haringhuizen A; Spillenaar Bilgen EJ; Hansson BME; de Wilt JHW; Kampman E; Winkels RM
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2139-2147. PubMed ID: 30120542
[TBL] [Abstract][Full Text] [Related]
31. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
32. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
33. Survival of patients with symptom- and screening-detected colorectal cancer.
Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
[TBL] [Abstract][Full Text] [Related]
34. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
35. Synchronous colorectal carcinoma: predisposing factors and characteristics.
Chin CC; Kuo YH; Chiang JM
Colorectal Dis; 2019 Apr; 21(4):432-440. PubMed ID: 30578740
[TBL] [Abstract][Full Text] [Related]
36. Oxidative Stress as a Biomarker for Predicting the Prognosis of Patients with Colorectal Cancer.
Sawai K; Goi T; Sakamoto S; Matsunaka T; Maegawa N; Koneri K
Oncology; 2022; 100(11):612-619. PubMed ID: 36116426
[TBL] [Abstract][Full Text] [Related]
37. Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response.
Vaughan-Shaw PG; Zgaga L; Ooi LY; Theodoratou E; Timofeeva M; Svinti V; Walker M; O'Sullivan F; Ewing A; Johnston S; Din FVN; Campbell H; Farrington SM; Dunlop MG
Gut; 2020 Jan; 69(1):103-111. PubMed ID: 31023832
[TBL] [Abstract][Full Text] [Related]
38. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
[TBL] [Abstract][Full Text] [Related]
39. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
40. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment.
Hoffmeister M; Jansen L; Rudolph A; Toth C; Kloor M; Roth W; Bläker H; Chang-Claude J; Brenner H
J Natl Cancer Inst; 2015 Jun; 107(6):djv045. PubMed ID: 25770147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
